Neuren Pharmaceuticals | NEU - Current Liabilities



Neuren Pharmaceuticals reported AUD45.76M in Current Liabilities for its fiscal semester ending in December of 2024.


Current Liabilities Change Date
Alaunos Therapeutics USD 4K 822K Oct/2024
Avita Medical AUD 20.16M 6.37M Dec/2024
Clinuvel Pharmaceuticals AUD 25.21M 4.17M Jun/2024
Dianthus Therapeutics USD 20.09M 1.64M Jun/2025
Genetic Signatures AUD 3.75M 1.48M Dec/2024
Ionis Pharmaceuticals USD 897.24M 646.94M Jun/2025
Medical Developments International AUD 6.37M 3.17M Dec/2024
Neuren Pharmaceuticals AUD 45.76M 36.79M Dec/2024
Organon & Co USD 2.8B 181M Jun/2025
Paradigm Biopharmaceuticals AUD 1.08M 2.28M Dec/2024
PYC Therapeutics AUD 11.38M 2.27M Dec/2024
Starpharma Holdings AUD 4.85M 1.81M Dec/2024
Tectonic Therapeutic USD 11.36M 250K Jun/2025
Telix Pharmaceuticals AUD 330.91M 72.54M Dec/2024
Viatris USD 7.13B 1.41B Jun/2025
Xeris Pharmaceuticals USD 95.17M 5.27M Jun/2025